← Back to Search


Cannabidiol for Alcoholism

Phase 2
Waitlist Available
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Screening 3 weeks
Treatment Varies
Follow Up 4-8 weeks
Awards & highlights

Study Summary

This trial will compare CBD to a placebo in reducing alcohol consumption for people with moderate alcohol use disorder.

Eligible Conditions
  • Alcoholism


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4-8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4-8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Alcohol Dependence/Craving
Drinks per Drinking Day
Secondary outcome measures
Sleep Quality
+1 more

Side effects data

From 2022 Phase 2 & 3 trial • 90 Patients • NCT04387617
Poor sleep
Poor Appetite
Study treatment Arm
CBD Oil Group
Control Group

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: Broad-spectrum CannabidiolExperimental Treatment1 Intervention
150mg/day of broad-spectrum cannabidiol, containing 0%THC.
Group II: Full-spectrum CannabidiolActive Control1 Intervention
150mg/day of full-spectrum cannabidiol, containing less than 0.3%THC.
Group III: PlaceboPlacebo Group1 Intervention
150mg/day of hemp-seed oil with no cannabinoids present.
First Studied
Drug Approval Stage
How many patients have taken this drug
Completed Phase 3

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor
1,746 Previous Clinical Trials
2,164,078 Total Patients Enrolled
12 Trials studying Alcoholism
1,671 Patients Enrolled for Alcoholism

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment of elderly individuals over 85 years old being sought in this clinical trial?

"This study is inviting participants aged between 21 and 60 years old."

Answered by AI

Has Cannabidiol been investigated in other investigations?

"Presently, there are 79 trials involving Cannabidiol and 16 of them have advanced to the third phase. Trials for this drug can be found in multiple locations across Brazil, with a particularly high concentration around Ribeirao Preto and Sao Paulo."

Answered by AI

What are the eligibility requirements for participation in this research project?

"This trial is searching for 45 individuals between the ages of 21 and 60 who have an alcohol drinking habit that meets DSM-V criteria as a moderate Alcohol Use Disorder (AUD). Participants should also report having had at least one heavy drinking day within the week prior to screening. Additionally, male applicants must consume no less than 21 standard drinks per week while females need 14 or more drinks per week. Lastly, patients must reside in close proximity to the medical centre; within 35 miles of its location."

Answered by AI

What is the current total of enrollees in this research project?

"Affirmative. Information on clinicaltrials.gov reveals that this experiment, which was initially posted on August 30th 2021, is actively searching for participants. 45 individuals need to be enrolled from 1 medical centre in total."

Answered by AI

Are there current opportunities to join this research study?

"Affirmative, clinicaltrials.gov has details to support that this medical trial is currently enrolling volunteers. The experiment was initiated on August 30th 2021 and most recently updated on February 22nd 2022. 45 patients are needed for the study at 1 site of operation."

Answered by AI

What is the primary goal of this clinical experiment?

"The primary outcome metric of this trial, measured within a 4-8 week window, is Alcohol Dependence/Craving. Secondary outcomes include the Beck Anxiety Inventory (scores range from 0 to 63), Pittsburgh Sleep Quality Index (scores range from 0 to 21) and McGill Pain Questionnaire (scores range from 0 to 78). These metrics measure anxiety levels, sleep quality and subjective pain level respectively."

Answered by AI

Is there any risk associated with the ingestion of Cannabidiol?

"We rate cannabidiol's safety with a score of 2. Even though it is undergoing phase 2 trials, there is evidence that suggests its innocuousness and lack of data suggesting efficacy."

Answered by AI
~12 spots leftby May 2025